Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT2 | O15382 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.46 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.46 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.46 |
| ▸ | SCN1A | P35498 | 3/20 | 0.44 |
| ▸ | SCN2A | Q99250 | 3/20 | 0.44 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HNF4A | P41235 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28001944 | 0.85 | KAT6A (0.46) | BCAT2MEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL10137801 | 0.79 | BCAT2 (0.57) | BCAT2MEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL21682896 | 0.76 | BCAT2 (0.53) | BCAT2MEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL28821966 | 0.76 | TTR (0.42) | MEN1KMT2ASMN1; SMN2GAAHTT | |
| SCHEMBL1775832 | 0.76 | SLC6A3 (0.74) | BCAT2MEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL29639748 | 0.76 | LMNA (0.57) | MEN1KMT2ASMN1; SMN2GAAKDM4E | |
| SCHEMBL27718824 | 0.76 | LMNA (0.57) | MEN1KMT2ASMN1; SMN2GAAKDM4E | |
| SCHEMBL28534106 | 0.76 | BCAT2 (0.57) | BCAT2MEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL28073219 | 0.76 | BCAT2 (0.57) | BCAT2MEN1KMT2ASMN1; SMN2GAA | |
| SCHEMBL29009563 | 0.75 | AKR1C3 (0.55) | KMT2ASMN1; SMN2GAAPOLBSLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312987-A1 | Method, kit and composition for non-destructive in situ repair or relining of deteriorated pipelines with a dual use system | APPLIED RESIN S.L. (ES) | 2023-10-05 | — | — | US | claimed |
| EP-4253819-A1 | METHOD, KIT AND COMPOSITION FOR NON-DESTRUCTIVE IN SITU REPAIR (RELINING) OF DETERIORATED PIPELINES WITH A DUAL USE SYSTEM | Applied Resin S.L. (ES) | 2023-10-04 | — | — | EP | claimed |
| WO-2026105750-A1 | HOLDER FOR CELLS, METHOD FOR HOLDING FLOATING CELLS, AND METHOD FOR RECOVERING FLOATING CELLS | 日産化学株式会社 | 2026-05-21 | — | — | WO | disclosed |
| US-12509608-B2 | Biological material adhesion inhibitor | NISSAN CHEMICAL CORPORATION (JP) | 2025-12-30 | — | — | US | disclosed |
| US-12427714-B2 | Functionalized product fabricated from a resin comprising a functional component and a polymeric resin, and method of making the same | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2025-09-30 | — | — | US | disclosed |
| US-12360294-B2 | 3D printed graded refractive index device | CARLETON UNIVERSITY (CA) | 2025-07-15 | — | — | US | disclosed |
| WO-2024257789-A1 | STRUCTURE FOR CELLS, METHOD FOR MANUFACTURING STRUCTURE FOR CELLS, AND METHOD FOR CULTURING CELLS | 日産化学株式会社 | 2024-12-19 | — | — | WO | disclosed |
| US-11958971-B2 | Photocurable composition, method for producing concave-convex structure, method for forming fine concave-convex pattern, and concave-convex structure | MITSUI CHEMICALS, INC. (JP) | 2024-04-16 | — | — | US | disclosed |
| US-11940634-B2 | 3D printed antenna | CARLETON UNIVERSITY (CA) | 2024-03-26 | — | — | US | disclosed |
| CN-110741463-B | Method for producing substrate with fine concave-convex pattern, resin composition, and laminate | 三井化学株式会社 | 2024-02-20 | — | — | CN | disclosed |
| CN-113423745-B | Method for producing polymer having compatibility with biological material | 日产化学株式会社 | 2024-01-09 | — | — | CN | disclosed |
| EP-1873174-A1 | PHOTOCURABLE COMPOSITION, ARTICLE WITH FINE PATTERN AND METHOD FOR PRODUCING SAME | Asahi Glass Company, Limited (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-7235331-B2 | Semi-Interpenetrating polymer network electrolyte, process for producing the same and battery using the same | SONY CORPORATION (JP) | 2007-06-26 | — | — | US | disclosed |
| US-6767933-B2 | CONTAINING CHARGE TRANSFER COMPOUND | BALLINA PTY LTD (AU) | 2004-07-27 | — | — | US | disclosed |
| US-20040044094-A1 | Radiation polymerisable compositions having accelerated cure | GARNETT JOHN LYNDON (AU) | 2004-03-04 | — | — | US | disclosed |
| US-6573009-B1 | Forming three dimensional network films; strength; ion conductivity | SONY CORPORATION (JP) | 2003-06-03 | — | — | US | disclosed |
| US-20030073755-A1 | Radiation polymerisable compositions | BALLINA PTY. LTD. (AU) | 2003-04-17 | — | — | US | disclosed |
| US-20030054257-A1 | Electrolyte compound, and electrolyte, process for producing the same and battery using the same | NODA KAZUHIRO (JP) | 2003-03-20 | — | — | US | disclosed |
| EP-1024502-A1 | COMPOSITION FOR ELECTROLYTE, ELECTROLYTE AND PROCESS FOR PRODUCING THE SAME, AND CELL CONTAINING THE SAME | Sony Corporation (JP) | 2000-08-02 | — | — | EP | disclosed |
| US-4738870-A | CONTAINING (HYDROXY)PHOSPHINALALKYL ACRYLATE | THE DOW CHEMICAL COMPANY (US) | 1988-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509608-B2 | Biological material adhesion inhibitor | ICAM1, EPCAM, VCAM1 | BCAT2 1190/4885MEN1 662/4885KMT2A 2938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.